ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹236 Cr | ₹8737 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -2.16% | -0.67% |
6 Month | 6.91% | 10.26% |
1 Year | 2.38% | 3.59% |
3 Year | 21.09% | 23.06% |
5 Year | - | 18.54% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 2.6% | 4.46% |
1 Year | 1.34% | 7.63% |
3 Year | 20.4% | 22.46% |
5 Year | - | 18.88% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 19.5% | 17.31% |
3 Year | 19.53% | 20.52% |
5 Year | - | 20.64% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.16% | 14.61% |
Sharp | 0.98% | 1.14% |
Beta | 0.94% | 0.90% |
Alpha | -1.87% | 0.72% |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.17 | 1.47 |
Mid Cap | 37.04 | 32.06 |
Small Cap | 32.68 | 31.79 |
Large Cap | 27.1 | 34.68 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.29 | 0.55 |
Healthcare | 91.09 | 99.45 |
Basic Materials | 5.09 | - |
Industrials | 1.81 | - |
Financial Services | 0.73 | - |
Top Comparisons
Tata Multi Asset Allocation Fund-Regular Plan-Growth
3Y Returns14.45%
UTI Multi Asset Allocation Fund - Regular Plan - Growth Option
3Y Returns18.63%
SBI Magnum Low Duration Fund - Regular Plan - Growth
3Y Returns6.99%
UTI Low Duration Fund - Regular Plan - Growth Option
3Y Returns7.35%
Franklin India ELSS Tax Saver Fund-Growth
3Y Returns19.05%
Bandhan ELSS Tax saver Fund - Regular Plan - Growth
3Y Returns15.63%
Aditya Birla Sun Life MidCap Fund-Growth
3Y Returns18.92%
Sundaram Mid Cap Fund Regular Plan - Growth
3Y Returns23.89%